- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
Clinical trial condition
Stage III Renal Cell Cancer
Explore clinical trials studying Stage III Renal Cell Cancer. Study availability and eligibility vary by location and protocol.
31 public trials
1 recruiting study
Stage III Renal Cell Cancer trial results
NCT02526511
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT02318771
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +39 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT01061411
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Academ Zienkenhuis Bij De University Amsterdam, Netherlands
- VU University Medical Center Amsterdam, Netherlands
NCT01846520
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT00005799
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- University of Colorado Denver, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States
NCT01026337
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01688973
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
- Locations
-
- University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States